Urgent.News

What's breaking now, across thousands of outlets.

Business

Standard Biotools Agrees To Sell Microfluidics Business To ARCHIMED

(RTTNews) - On Monday, Standard BioTools Inc. (NASDAQ: LAB) announced that it has signed a definitive agreement to sell its Microfluidics business to ARCHIMED, an investment firm focused on the healthcare industry.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Business

More from Monday 5 October →